Helicobacter pylori infection and the use of NSAIDs (original) (raw)
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial
Harald Vonkeman
Helicobacter, 2007
View PDFchevron_right
Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users
Xavier Calvet
Alimentary Pharmacology and Therapeutics, 2005
View PDFchevron_right
Changing trends in peptic ulcer disease: the rise of NSAID-induced and fall of H pylori-induced ulcers
Munir Pirmohamed
Gut, 2011
View PDFchevron_right
The Association of Helicobacter Pylori Infection and Non-Steroidal Anti-Inflammatory Drugs in Peptic-Ulcer Disease
Sergio Zepeda-gomez
American Journal of Gastroenterology
View PDFchevron_right
Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users
Xavier Calvet
Alimentary Pharmacology and Therapeutics, 2000
View PDFchevron_right
Comparative study between H. Pylori induced and NSAIDs induced peptic ulcer
Krishnendhu Ajayakumar
Journal of Current Medical Research and Opinion, 2021
View PDFchevron_right
The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010
Munir Pirmohamed
Alimentary Pharmacology & Therapeutics, 2012
View PDFchevron_right
Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users
Pilar Roncales
The American Journal of Gastroenterology, 2015
View PDFchevron_right
The Role ofHelicobacter pyloriand NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer
Cem Sezer
Gastroenterology Research and Practice, 2012
View PDFchevron_right
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users - a randomized trial
KC Lai
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Lansoprazole reduces ulcer relapse after eradication of helicobacter pylori in NSAIDS users
Man-fung Yuen
Gastroenterology, 2000
View PDFchevron_right
Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin
Jiro Watari
Journal of Gastroenterology, 2012
View PDFchevron_right
Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori
Varocha Mahachai
Journal of the Medical Association of Thailand Chotmaihet Thangphaet, 2009
View PDFchevron_right
Guidelines for prevention of NSAID-related ulcer complications
H. Parkman
American Journal of Gastroenterology, 2009
View PDFchevron_right
Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study
Harald Vonkeman
Arthritis Research & Therapy, 2007
View PDFchevron_right
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects
Marilisa Franceschi
Alimentary Pharmacology & Therapeutics, 2000
View PDFchevron_right
Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX2 Inhibitors
Neville D Yeomans
The American journal of …, 2006
View PDFchevron_right
Management of Peptic Ulcers: Emerging Issues
James Freston
World Journal of Surgery, 2000
View PDFchevron_right
Comparison of demographic, clinical and endoscopic characteristics of peptic ulcer due to Helicobacter Pylori and NSAIDs
Caspian Journal of Internal Medicine (CJIM)
Caspian Journal of Internal Medicine, 2010
View PDFchevron_right
Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy
Lester Arguelles
The Journal of rheumatology, 2002
View PDFchevron_right
Outcome of Peptic Ulcer Bleeding, Nonsteroidal Anti-inflammatory Drug Use, and Infection
Erik Rauws
Clinical Gastroenterology and Hepatology, 2005
View PDFchevron_right
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate
Rupert Leong
The American Journal of Medicine, 2001
View PDFchevron_right
Role of Helicobacter pylori Infection in Gastroduodenal Damage in Patients Starting NSAID Therapy: 4 Months Follow-Up Study
Tamara Alempijevic
Digestive Diseases and Sciences, 2010
View PDFchevron_right
Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDs
José Eluf-Neto
International journal of clinical practice. Supplement, 2003
View PDFchevron_right
Specifics of Helicobacter pylori Infection/NSAID Effects in the Elderly
Mladen Davidovic
View PDFchevron_right
Thong-Ngam D, Chayanupatkul M, Klaikeaw N, et al. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori
Varocha Mahachai
Journal of the Medical Association of Thailand = Chotmaihet thangphaet
View PDFchevron_right
Frequency of NSAID induced peptic ulcer disease
Javed Yakoob
JPMA. The Journal of the Pakistan Medical Association, 2006
View PDFchevron_right
Risk of Peptic Ulcer Hospitalizations in Users of NSAIDs With Gastroprotective Cotherapy Versus Coxibs
Walter Smalley
Gastroenterology, 2007
View PDFchevron_right
Helicobacter pylori Eradication in Patients on Long-term Treatment With NSAIDs Reduces the Severity of Gastritis
Ernst J Kuipers
Journal of Clinical Gastroenterology, 2009
View PDFchevron_right
Ulcer risk factors: Interactions between Helicobacter pylori infection, nonsteroidal use, and age
Timothy Schubert
The American Journal of Medicine, 1993
View PDFchevron_right
Management of peptic ulcer disease not related to Helicobacter
Neville D Yeomans
Journal of Gastroenterology and Hepatology, 2002
View PDFchevron_right
Conventional and Novel Pharmaceutical Dosage Forms on Prevention of Gastric Ulcers
I. Ozguney
intechopen.com
View PDFchevron_right